Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [896]

The translational element of the WIN consortium

Dr Brian Leyland-Jones - WIN Head of Fundraising Committee

The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )

How the WIN consortium achieves its goals

Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA

How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )

KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after...

Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea

KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after two or more lines of prior therapy ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity...

Prof Shoba Navai - Baylor College of Medicine, Houston, USA

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )

GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration...

Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas...

GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer (1/2) ( Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steuber )

GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)

GU Debates 2019: Practice-changing developments in urothelial cancer (2/2) ( )

New developments in soft tissue and bone sarcoma research

Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands

New developments in soft tissue and bone sarcoma research ( Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands )

Updates from the BCON trial: Longterm outcomes of hypoxia modification in...

Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK

Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation ( Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK )

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated...

Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patients with mCRPC ( Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA )

Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical...

Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA

Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical cystectomy: Urothelial carcinoma subgroup analysis ( Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA )

ASCO GU 2019: Updates on treatment and management of bladder cancer

Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim...

ASCO GU 2019: Updates on treatment and management of bladder cancer ( Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt, Dr Andrea Necchi )

Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised...

Dr Nicholas van As - The Royal Marsden NHS Foundation Trust, London, UK

Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised prostate cancer ( Dr Nicholas van As - The Royal Marsden NHS Foundation Trust, London, UK )

More from ecancer